서울특별시 서울의료원은 서울특별시 중랑구 신내로 156 에 위치한 서울특별시 산하 시립 종합병원이다. 지역거점공공병원, 권역응급의료센터로 지정되어 있다.

During the past decade, Seoul Medical Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul Medical Center" #1 sponsor was "Seoul Medical Center" with 5 trials, followed by "HK inno.N Corporation" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Asan Medical Center" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul Medical Center" #1 collaborator was "Daiichi Sankyo Korea Co., Ltd." with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator, "Daegu Metropolitan City, Korea" with 1 trials as a collaborator, "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Kyungpook National University Hospital" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Seoul Medical Center" are "COVID-19" (6 trials), "Essential Hypertension" (3 trials), "Brain Ischemia" (2 trials), "General Anesthesia" (2 trials) and "Laparoscopic Cholecystectomy" (2 trials). Many other conditions were trialed in "Seoul Medical Center" in a lesser frequency.

Most popular intervention types in "Seoul Medical Center" are "Drug" (26 trials), "Device" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials), "Amlodipine 5mg" (2 trials), "Candesartan cilexetil 16mg" (2 trials) and "Remdesivir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seoul Medical Center" are 31 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Seoul Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Seoul Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".